Total Funding
68
34
Total FundingDebt Financing raised
Growth Score
24 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
167870
XEMPERIA is a science-driven company pioneering next-generation blood tests for cancer screening and monitoring.
- Sarah Cattin: Chief Technology Officer
About the Company
At XEMPERIA, we are pioneering a groundbreaking concept for a blood test that effectively detects breast cancer at its earliest stage by harnessing the body’s immune response. Suitable for any women and age this innovative test offers superior performance to mammography and will serve as the first-line option in the breast cancer screening process.
